top of page
Proteons in the Proteometer

THE CANARY IN
THE FERMENTOR

Novilytic Canary

Expedite Molecular Structure Analysis With The Proteometer®

Arrow Down

SOLUTIONS

Zoomed Proteometer Kit.jpg
CONVERT LCs INTO PROTEOFORM METERS

Proteometer-L Kit: Coming Feb. 2023

World's first technology for at-line molecular structure analysis!

Lifestyle 2.jpg

ENHANCED APPROACH TO PROCESS ANALYTICAL TECHNOLOGY

MASC®, Sequestron®, Luminon®

Learn about the technology & components behind Proteometer Kits

PHOTO%201_edited.jpg
NOVIPLEX™ PLASMA COLLECTION SOLUTIONS
(NOW TELIMMUNE)

Whole blood to dried plasma in a quantified volume. Perfect for remote sample collection. 

Now sold at Telimmune.com

Bioreactor Banner Option 1 - pcd22Jul202

ABOUT

Novilytic is a molecular recognition company that utilizes nanotechnology to monitor the quality of lifesaving medicines.

--


A canary in a coal mine saved the lives of thousands of miners. Novilytic takes this same premise and applies it to medicines developed in modern drug bioreactors (fermenters).

 

By recognizing molecular structure early and often, we can help ensure quality and consistency.

 

Existing methods take 4-8 hours to evaluate medication quality. Our technology performs this task in an average of 10 minutes. The results allow pharmaceutical companies to alter their batches’ process parameters in a timely manner and keep them compliant with regulatory bodies.

 

We call this patented technology "The Proteometer," which is short for Proteoform Meter.

TESTIMONIALS

Architectural Structure

“The Proteometer is expected to play a central role in the development and commercialization of next-level biological manufacturing control strategies.

Eugene L. Inman, Ph.D.

Pharmaceutical Quality Consultant

Retired Eli Lilly and Company

Architectural Structure

“Novilytic’s Proteometer is a disruptive breakthrough that finally solves the FDA's requirement to continuously monitor t-mAb proteoforms during fermentation.”

Martin Long, BSc.
Performance Validation, Inc. – President & CEO
(Analytical Sciences Business, Brooks Life Sciences, Thermo, Perkin Elmer)

Architectural Structure

“We couldn’t be more thrilled by the results of our validation and stability analyses using the NoviPlex dry plasma cards and look forward to using them in our DMD clinical trial.”

Ines Macias-Perez, Ph.D

Principle Scientist, Product Development

Cumberland Pharmaceuticals

> 5,000

Bioreactors Globally

$8M

Raw Material Costs

0 PAT In-Line

Massive Industry Gap

The Proteometer Provides the Solution

bottom of page